Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 Unicycive Therapeutics UNCY $765M	1,083% upside 3 price targets	0
2	2 Sensei Biotherapeutics SNSE $9.65M	1,031% upside 3 price targets	0
3	3 Zura Bio ZURA $69.9M	896% upside 4 price targets	0
4	4 NRX Pharmaceuticals NRXP $56.4M	871% upside 3 price targets	0
5	5 Cabaletta Bio CABA $161M	785% upside 6 price targets	0
6	6 4D Molecular Therapeutics FDMT $191M	764% upside 3 price targets	0
7	7 Metagenomi MGX $54.2M	705% upside 3 price targets	0
8	8 Nkarta NKTX $126M	691% upside 4 price targets	0
9	9 Atossa Therapeutics ATOS $102M	681% upside 3 price targets	0
10	10 Aclaris Therapeutics ACRS $157M	659% upside 3 price targets	0
11	11 Compass Therapeutics CMPX $332M	650% upside 4 price targets	0
12	12 Elevation Oncology ELEV $22.6M	638% upside 5 price targets	0
13	IRD 13 Opus Genetics, Inc. Common Stock IRD $56.7M	610% upside 4 price targets	0
14	14 Clene CLNN $38.4M	583% upside 4 price targets	0
15	15 SAB Biotherapeutics SABS $16.6M	570% upside 3 price targets	0
16	16 Larimar Therapeutics LRMR $166M	569% upside 3 price targets	0
17	ALMS 17 Alumis Inc. Common Stock ALMS $295M	564% upside 3 price targets	0
18	18 Allogene Therapeutics ALLO $269M	564% upside 6 price targets	0
19	19 Karyopharm Therapeutics KPTI $37.8M	547% upside 3 price targets	0
20	20 Astria Therapeutics ATXS $331M	526% upside 3 price targets	0
21	21 Corbus Pharmaceuticals CRBP $101M	523% upside 3 price targets	0
22	22 Humacyte HUMA $358M	520% upside 3 price targets	0
23	23 Zentalis Pharmaceuticals ZNTL $93.5M	515% upside 3 price targets	0
24	ADAP 24 Adaptimmune Therapeutics ADAP $67.1M	502% upside 5 price targets	0
25	25 Olema Pharmaceuticals OLMA $283M	493% upside 4 price targets	0

12345

64